Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Teva Sees Off Emergent’s US Narcan Appeal In ‘A Close Case’
‘We Are A Court Of Review, Not A Court Of First Resort,’ Federal Circuit Underlines
Feb 14 2022
•
By
Dean Rudge
Teva hit the target in both rulings • Source: Alamy
More from Legal & IP
More from Generics Bulletin